MedPath

TOPAMAX 25MG

TOPAMAX 25MG

Approved
DIN Number

02230893

Drug Class

Human

Market Date

Mar 25, 1997

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230893
AIG Number0132938001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX11 TOPIRAMATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

TOPIRAMATEActive
Strength: 25 MG
Monograph: TOPIRAMATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.